Regina Clementi

860 total citations · 1 hit paper
15 papers, 542 citations indexed

About

Regina Clementi is a scholar working on Pathology and Forensic Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Regina Clementi has authored 15 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Regina Clementi's work include Lymphoma Diagnosis and Treatment (5 papers), Cardiovascular and exercise physiology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Regina Clementi is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Cardiovascular and exercise physiology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Regina Clementi collaborates with scholars based in United States, Australia and Canada. Regina Clementi's co-authors include David Simpson, Brad S. Kahl, David MacDonald, Mihaela Munteanu, Ian W. Flinn, Samar Issa, John M. Burke, Peter Wood, Mark Hertzberg and Michael Craig and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Regina Clementi

15 papers receiving 532 citations

Hit Papers

Randomized trial of bendamustine-rituximab or R-CHOP/R-CV... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
    2014 419 citations Ian W. Flinn, Richard van der Jagt et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Regina Clementi United States 6 429 335 238 80 53 15 542
Andrea Knapp Switzerland 15 553 1.3× 437 1.3× 179 0.8× 80 1.0× 58 1.1× 45 731
András Rosta Hungary 9 416 1.0× 118 0.4× 386 1.6× 24 0.3× 76 1.4× 19 588
M. Cozar Spain 12 97 0.2× 121 0.4× 47 0.2× 32 0.4× 137 2.6× 49 458
John Frye United States 10 101 0.2× 286 0.9× 46 0.2× 23 0.3× 172 3.2× 24 754
Fulvio Brema Italy 12 63 0.1× 388 1.2× 31 0.1× 17 0.2× 67 1.3× 36 562
N. Eche France 11 55 0.1× 113 0.3× 33 0.1× 20 0.3× 61 1.2× 25 361
Jules H. Blank United States 10 255 0.6× 242 0.7× 154 0.6× 19 0.2× 77 1.5× 18 441
Hyeok Shim South Korea 15 170 0.4× 155 0.5× 73 0.3× 67 0.8× 72 1.4× 37 619
T. Christopher Windham United States 7 61 0.1× 177 0.5× 27 0.1× 14 0.2× 110 2.1× 14 438
Sabine Kajita Japan 12 76 0.2× 135 0.4× 25 0.1× 20 0.3× 30 0.6× 25 492

Countries citing papers authored by Regina Clementi

Since Specialization
Citations

This map shows the geographic impact of Regina Clementi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina Clementi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina Clementi more than expected).

Fields of papers citing papers by Regina Clementi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regina Clementi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina Clementi. The network helps show where Regina Clementi may publish in the future.

Co-authorship network of co-authors of Regina Clementi

This figure shows the co-authorship network connecting the top 25 collaborators of Regina Clementi. A scholar is included among the top collaborators of Regina Clementi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regina Clementi. Regina Clementi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zheng, Bo, Shinya Goto, Regina Clementi, et al.. (2022). Effect of CSL112 (apolipoprotein A‐I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross‐study comparison. Clinical and Translational Science. 15(10). 2331–2341. 5 indexed citations
2.
Tortorici, Michael A., et al.. (2021). CSL112 (APOLIPOPROTEIN A-I [HUMAN]) SIMILARLY ENHANCES CHOLESTEROL EFFLUX CAPACITY IN JAPANESE AND CAUCASIAN SUBJECTS: FINDINGS FROM A PHASE 1 STUDY. Journal of the American College of Cardiology. 77(18). 131–131. 2 indexed citations
3.
Flinn, Ian W., Richard van der Jagt, Brad S. Kahl, et al.. (2014). Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. Blood. 123(19). 2944–2952. 419 indexed citations breakdown →
4.
5.
Hexner, Elizabeth O., Gail J. Roboz, Ron Hoffman, et al.. (2013). Open‐label study of oral CEP‐701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2‐V617F mutation. British Journal of Haematology. 164(1). 83–93. 21 indexed citations
6.
MacDonald, David, Richard van der Jagt, John M. Burke, et al.. (2013). Different safety profiles of first-line bendamustine-rituximab (BR), R-CHOP, and R-CVP in an open-label, randomized study of indolent non-Hodgkin lymphoma (NHL) and mantle cell lymphoma (MCL): The BRIGHT study.. Journal of Clinical Oncology. 31(15_suppl). 8565–8565. 2 indexed citations
7.
8.
9.
Vlasses, Peter H., Heschi H. Rotmensch, Brian N. Swanson, Regina Clementi, & R Ferguson. (1989). Effect of repeated doses of L-5-hydroxytryptophan and carbidopa on prolactin and aldosterone secretion in man. Journal of Endocrinological Investigation. 12(2). 87–91. 2 indexed citations
10.
Conner, Dale P., et al.. (1987). Hemodynamic Effects During Rest and Exercise of Bucindolol in Hypertensive Men. The Journal of Clinical Pharmacology. 27(4). 300–303. 2 indexed citations
11.
Mojaverian, Parviz, et al.. (1986). Effect of Food on the Bioavailability of Lisinopril, a Nonsulfhydryl Angiotensin-Converting Enzyme Inhibitor. Journal of Pharmaceutical Sciences. 75(4). 395–397. 29 indexed citations
12.
Ferguson, Roger K., et al.. (1983). Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.. PubMed. 3(2 Pt 1). 125–30. 6 indexed citations
13.
Ferguson, Roger K., et al.. (1983). Effect of Captopril and Propranolol, Alone and in Combination, on the Responses to Isometric and Dynamic Exercise in Normotensive and Hypertensive Men. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 3(2P1). 125–130. 1 indexed citations
14.
Ferguson, Roger K., et al.. (1983). Effect of Captopril and Propranolol, Alone and in Combination, on the Responses to Isometric and Dynamic Exercise in Normotensive and Hypertensive Men. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 3(2). 125–130. 5 indexed citations
15.
Vlasses, Peter H., et al.. (1981). Adrenocortical function after chronic inhalation of fluocortinbutyl and beclomethasone dipropionate. Clinical Pharmacology & Therapeutics. 29(5). 643–649. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Knapp Breakdown of academic impact, for papers by András Rosta Breakdown of academic impact, for papers by M. Cozar Breakdown of academic impact, for papers by John Frye Breakdown of academic impact, for papers by Fulvio Brema Breakdown of academic impact, for papers by N. Eche Breakdown of academic impact, for papers by Jules H. Blank Breakdown of academic impact, for papers by Hyeok Shim Breakdown of academic impact, for papers by T. Christopher Windham Breakdown of academic impact, for papers by Sabine Kajita
Rankless by CCL
2026